Seasonal influenza A H1N1pdm09 virus and severe outcomes: A reason for broader vaccination in non-elderly, at-risk people

PLoS ONE

Volumn 11, Issue 11, 2016, Pages

  Minchole, Elisa ^a   Figueredo, Ana L ^a   Omeñaca, Manuel ^a   Panadero, Carolina ^a   Royo, Laura ^a   Vengoechea, Jose J ^a   Fandos, Sergio ^a   De Pablo, Francisco ^a   Bello, Salvador ^a  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; VIRUS VACCINE; ANTIVIRUS AGENT; OSELTAMIVIR;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGE DISTRIBUTION; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HIGH RISK PATIENT; HUMAN; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PNEUMONIA; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEASONAL INFLUENZA; SEPTIC SHOCK; ACUTE DISEASE; ADOLESCENT; AGE; AGED; COMPLICATION; DRUG EFFECTS; HOSPITALIZATION; INFLUENZA; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); ISOLATION AND PURIFICATION; MIDDLE AGED; SEASON; TREATMENT OUTCOME; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ACUTE DISEASE; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; HOSPITALIZATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; OSELTAMIVIR; PNEUMONIA; RESPIRATORY DISTRESS SYNDROME, ADULT; RETROSPECTIVE STUDIES; RISK FACTORS; SEASONS; SHOCK, SEPTIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84994796728     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0165711     Document Type: Article

References (45)

1. Reed C, Chaves SS, Perez A, D'Mello T, Daily Kirley P, Aragon D, et al. Complications among adults hospitalized with influenza: a comparison of seasonal influenza and the 2009 H1N1 pandemic. Clin Infect Dis 2014; 59:166-74. doi:10.1093/cid/ciu285 PMID: 24785230
2. Hayward AC, Fragaszy EB, Bermingham A, Wang L, Copas A, Edmunds WJ, et al. Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study. Lancet Respir Med 2014; 2:445-54. doi:10.1016/S2213-2600(14)70034-7 PMID: 24717637
3. Lehners N, Geis S, Eisenbach C, Neben K, Schnitzler P. Changes in Severity of Influenza A(H1N1) pdm09 Infection from Pandemic to First Postpandemic Season, Germany. Emerg Infect Dis 2013; 19:748-55. doi:10.3201/eid1905.130034 PMID: 23697801
4. Fineberg HV Pandemic Preparedness and Response-Lessons from the H1N1 Influenza of 2009. N Engl J Med 2014; 370:1335-42. doi:10.1056/NEJMra1208802 PMID: 24693893
5. Simonsen L, Spreeuwenberg P, Lustig R, Taylor RJ, Fleming DM, Kroneman M, et al. Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study. PLoS Med 2013; 10:e1001558. doi:10.1371/journal.pmed.1001558 PMID: 24302890
6. Radigan KA, Mutlu GM. Markers of Prognosis Specific to Influenza Infection: Are We There Yet? Am J Respir Crit Care Med. 2014; 189 (10):1159-1160. doi:10.1164/rccm.201403-0587ED PMID: 24832741
7. Kidd M. Influenza viruses: update on epidemiology, clinical features, treatment and vaccination. Curr Opin Pulm Med 2014; 20:242-6. doi:10.1097/MCP.0000000000000049 PMID: 24637227
8. Shrestha SS, Swerdlow DL, Borse RH, Prabhu VS, Finelli L, Atkins CY, et al. Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). Clin Infect Dis 2011; 52(SUPPL. 1):S75-82.
9. Cox CM, D'Mello T, Perez A, Reingold A, Gershman K, Yousey-Hindes K, et al. Increase in rates of hospitalization due to laboratory-confirmed influenza among children and adults during the 2009-10 influenza pandemic. J Infect Dis 2012; 206:1350-8. doi:10.1093/infdis/jis517 PMID: 23002448
10. Liang W, Feng L, Xu C, Xiang N, Zhang Y, Shu Y, et al. Response to the first wave of pandemic (H1N1) 2009: experiences and lessons learnt from China. Public Health 2012; 126: 427-436. doi:10.1016/j.puhe.2012.02.008 PMID: 22516790
11. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361:1945-52. doi:10.1056/NEJMoa0906453 PMID: 19745214
12. Weil M, Shohat T, Bromberg M, Bassal R, Dichtiar R, Mandelboim M, et al. The dynamics of infection and the persistence of immunity to A(H1N1)pdm09 virus in Israel. Influenza Other Respir Viruses 2013; 7:838-46. doi:10.1111/irv. 12071 PMID: 23280061
13. Sherbany H. McCauley J, Meningher T, Hindiyeh M, Dichtiar R, Markovich MP, et al. Return of pandemic H1N1 influenza virus. BMC Infect Dis 2014; 14:710. doi:10.1186/s12879-014-0710-1 PMID: 25551676
14. Meningher T Hindiyeh M, Regev L, Sherbany H, Mendelson E, Mandelboim M, et al. Relationships between A(H1N1)pdm09 influenza infection and infections with other respiratory viruses. Influenza and Other Respiratory Viruses 2014; 8: 422-30. doi:10.1111/irv.12249 PMID: 24698156
15. Kidd M. Influenza viruses: update on epidemiology, clinical features, treatment and vaccination. Curr Opin Pulm Med 2014; 20:242-6. doi:10.1097/MCP.0000000000000049 PMID: 24637227
16. Mertz D, Kim TH, Johnstone J, Lam PP, Science M, Kuster SP, et al. Populationsat risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ 2013; 347:f5061. doi:10.1136/bmj.f5061 PMID: 23974637
17. Santa-Olalla Peralta P, Cortes-García M, Vicente-Herrero M, Castrillo-Villamandos C, Arias-Bohigas P, Pachon-del Amo I, et al. Risk factors for disease severity among hospitalised patients with 2009 pandemic influenza A (H1N1) in Spain, April-December 2009. Euro Surveill 2010; 15(38) pii:19667. PMID: 20929651
18. Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Al Khuwaitir TS, Al Mamun A, et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med 2014; 2:395-404. doi:10.1016/S2213-2600(14)70041-4 PMID: 24815805
19. Viasus D, Cordero E, Rodriguez-Bano J, Oteo JA, Fernandez-Navarro A, Ortega L, et al. Changes in epidemiology, clinical features and severity of influenza A (H1N1) 2009 pneumonia in the first post-pandemic influenza season. Clin Microbiol Infect 2012; 18:E55-62. doi:10.1111/j.1469-0691.2011.03753.x PMID: 22264321
20. Chowell G, Bertozzi SM, Colchero MA, Lopez-Gatell H, Alpuche-Aranda C, Hernandez M, et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 2009; 361:674-9, doi:10.1056/NEJMoa0904023 PMID: 19564633
21. Kok J, Blyth CC, Foo H, Bailey MJ, Pilcher DV, Webb SA, et al. Viral pneumonitis is increased in obese patients during the first wave of pandemic A(H1N1) 2009 virus. PLoS One 2013; 8:e55631. doi:10.1371/journal.pone.0055631 PMID: 23418448
22. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009; 374:451-8. doi:10.1016/S0140-6736(09)61304-0 PMID: 19643469
23. Donaldson LJ, Rutter PD, Ellis BM, Greaves FE, Mytton OT, Pebody RG, et al. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ 2009; 339:b5213. doi:10.1136/bmj.b5213 PMID: 20007665
24. Belongia EA, Irving SA, Waring SC, Coleman LA, Meece JK, Vandermause M, et al. Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) infections JAMA 2010; 304:1091-8. doi:10.1001/jama.2010.1277 PMID: 20823435
25. Yap J, Tan CH, Cook AR, Loh JP, Tambyah PA, Tan BH, et al. Differing clinical characteristics between influenza strains among young healthy adults in the tropics. BMC Infect Dis 2012; 12:12. doi:10.1186/1471-2334-12-12 PMID: 22264216
26. Lee N, Chan PK, Lui GC, Wong BC, Sin WW, Choi KW, et al. Complications and outcomes of pandemic 2009 influenza A (H1N1) virus infection in hospitalized adults: how do they differ from those in seasonal influenza? J Infect Dis. 2011; 203:1739-47. doi:10.1093/infdis/jir187 PMID: 21606532
27. Rahamat-Langendoen JC, Tutuhatunewa ED, Scholvinck EH, Hak E, Koopmans M, Niesters HG, et al. Influenza in the immediate post-pandemic era: a comparison with seasonal and pandemic influenza in hospitalized patients. J Clin Virol 2012; 54:135-40. doi:10.1016/j.jcv.2012.02.010 PMID: 22398034
28. Chaves SS, Aragon D, Bennett N, Cooper T, D'Mello T, Farley M, et al. Patients hospitalized with laboratory-confirmed influenza during the 2010-2011 influenza season: exploring disease severity by virus type and subtype. J Infect Dis 2013; 208:1305-14. doi:10.1093/infdis/jit316 PMID: 23863950
29. Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hayden FG, et al. Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2009; 48:1003-32. doi:10.1086/598513 PMID: 19281331
30. Dalton CB, Cretikos MA, Durrheim DN, Seppelt IM, Rawlinson WD, Dwyer DE. Comparison of adult patients hospitalised with pandemic (H1N1) 2009 influenza and seasonal influenza during the "PROTECT" phase of the pandemic response. Med J Aust 2010; 192:357-8. PMID: 20376993
31. van den Brand JM, Stittelaar KJ, van Amerongen G, Reperant L, de Waal L, Osterhaus AD, et al. Comparison of temporal and spatial dynamics of seasonal H3N2, pandemic H1N1 and highly pathogenic avian influenza H5N1 virus infections in ferrets. PLoS One 2012; 7:e42343. doi:10.1371/journal.pone.0042343 PMID: 22905124
32. Guarner J, Falcon-Escobedo R. Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses. Arch Med Res 2009; 40:655-61. doi:10.1016/j.arcmed.2009.10.001 PMID: 20304252
33. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008; 198:962-70. doi:10.1086/591708 PMID: 18710327
34. Jamieson AM, Pasman L, Yu S, Gamradt P, Homer RJ, Decker T, et al. Role of tissue protection in lethal respiratory viral-bacterial coinfection. Science. 2013; 340:1230-4. doi:10.1126/science.1233632 PMID: 23618765
35. Cillóniz C, Ewig S, Menéndez R, Ferrer M, Polverino E, Reyes S, et al. Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia. J Infect. 2012; 65:223-30. doi:10.1016/j.jinf.2012.04.009 PMID: 22543245
36. Martín-Loeches I, Sanchez-Corral A, Diaz E, Granada RM, Zaragoza R, Villavicencio C, et al. Community-acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A(H1N1) virus. Chest. 2011; 139:555-62. doi:10.1378/chest.10-1396 PMID: 20930007
37. Centers for Disease Control and Prevention (CDC). Estimated influenza illnesses and hospitalizations averted by influenza vaccination-United States, 2012-13 influenza season. MMWR Morb Mortal Wkly. Rep 2013; 62:997-1000.
38. Castilla J, Godoy P, Domínguez A, Martínez-Baz I, Astray J, Martín V, et al. Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza. Clin Infect Dis 2013; 57:167-75. doi:10.1093/cid/cit194 PMID: 23532475
39. Catania J, Que LG, Govert JA, Hollingsworth JW, Wolfe CR. High intensive care unit admission rate for 2013-2014 influenza is associated with a low rate of vaccination. Am J Respir Crit Care Med 2014; 189:485-487. doi:10.1164/rccm.201401-0066LE PMID: 24512430
40. Guihot A, Luyt C-E, Parrot A, Rousset D, Cavaillon JM, Boutolleau D, et al. Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection. Am J Respir Crit Care Med 2014; 189:1240-9. doi:10.1164/rccm.201311-2071OC PMID: 24646009
41. Grijalva CG, Zhu Y, Williams DJ, Self WH, Ampofo K, Pavia AT, et al. Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination. JAMA. 2015 Oct 13; 314(14):1488-97. doi:10.1001/jama.2015.12160 PMID: 26436611
42. Jimenez-Jorge S, Pozo F, de Mateo S, Delgado-Sanz C, Casas I, García-Cenoz M, et al, on behalf of the Spanish Influenza Sentinel Surveillance System (SISS). Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study. Euro Surveillance. 2014; 19:20727. PMID: 24626206
43. Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 1998; 178:53-60. PMID: 9652423
44. Adalja AA Comparing severity and outcomes for seasonal and 2009 H1N1 infections. JAMA 2011: 305:39-40. doi:10.1001/jama.2010.1888 PMID: 21205963
45. Widdowson MA, Iuliano AD, Dawood FS. Challenges to global pandemic mortality estimation. Lancet Infect Dis. 2014; 14:670-2. doi:10.1016/S1473-3099(14)70835-7 PMID: 25056013